Region:Asia
Author(s):Shubham
Product Code:KRAD2599
Pages:80
Published On:January 2026
By Drug Type:The market is segmented into two primary categories: pure generic drugs and branded generics. Pure generic drugs are typically less expensive and are often preferred by cost-sensitive consumers and public hospitals seeking to optimize treatment costs in tenders and reimbursement schemes. In contrast, branded generics, which are marketed under a brand name but are chemically identical in active ingredients to originator products, appeal to consumers and physicians seeking perceived quality, consistent supply, and strong manufacturer reputation. The demand for branded generics has been increasing in urban areas due to rising consumer awareness, marketing efforts by domestic manufacturers, and trust in established brands that comply with international GMP and quality standards.
By Route of Administration:The market is further segmented by route of administration, including oral, parenteral (injectables), topical, inhalation, and others. Oral administration dominates the market due to its convenience, patient adherence, and suitability for a wide range of chronic therapies such as antihypertensives, antidiabetics, and cardiovascular drugs, which are increasingly prescribed in generic form. Parenteral administration is also significant, particularly for antibiotics, oncology medicines, and hospital-based therapies that require rapid absorption or are not suitable for oral intake, with demand supported by hospital procurement of cost-effective generic injectables. The increasing prevalence of chronic and serious conditions treated in hospital settings has led to a growing demand for injectables, while topical, inhalation, and other routes serve important but more specialized niches in dermatology, respiratory care, and emergency medicine.
The Vietnam Generic Pharmaceuticals Market is characterized by a dynamic mix of regional and international players. Leading participants such as DHG Pharmaceutical JSC, Traphaco JSC, Imexpharm Corporation, Domesco Medical Import-Export JSC, OPC Pharmaceutical JSC, Pymepharco JSC, Mekophar Chemical Pharmaceutical JSC, SPM JSC, Vimedimex Medi-Pharma JSC, Sanofi Vietnam, Bayer Vietnam, Novartis Vietnam, Pfizer Vietnam, GSK Vietnam, Abbott Vietnam contribute to innovation, geographic expansion, and service delivery in this space, with domestic firms particularly strong in cost-effective generics and over-the-counter products and multinationals focusing on higher-value and specialty portfolios.
The Vietnam generic pharmaceuticals market is poised for significant growth, driven by increasing healthcare expenditure and a rising prevalence of chronic diseases. As the government continues to promote generics through supportive policies, local manufacturers are expected to enhance their production capabilities. Additionally, the adoption of digital health technologies will facilitate better access to medications. Overall, the market is likely to evolve, focusing on affordability and accessibility, while addressing regulatory challenges to ensure sustainable growth.
| Segment | Sub-Segments |
|---|---|
| By Drug Type | Pure generic drugs Branded generics |
| By Route of Administration | Oral Parenteral (injectables) Topical Inhalation Others |
| By Therapeutic Area | Cardiovascular and metabolic disorders Anti-infective and vaccines Oncology Central nervous system (neurology & psychiatry) Gastrointestinal, respiratory, and others |
| By Distribution Channel | Hospital (ETC) channel Retail pharmacies and drug stores (OTC) Online / e-pharmacies |
| By Product Type | Prescription generics Over-the-counter (OTC) generics |
| By Manufacturing Origin | Domestically manufactured generics Imported generics |
| By Region | Northern Vietnam Central Vietnam Southern Vietnam |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Pharmacy Retailers | 120 | Pharmacy Owners, Store Managers |
| Healthcare Providers | 100 | Doctors, Nurses, Healthcare Administrators |
| Generic Drug Manufacturers | 80 | Production Managers, Quality Control Officers |
| Regulatory Bodies | 60 | Regulatory Affairs Specialists, Policy Makers |
| Patient Advocacy Groups | 70 | Patient Representatives, Health Advocates |
The Vietnam Generic Pharmaceuticals Market is valued at approximately USD 3.2 billion, reflecting significant growth driven by the demand for affordable medications and government initiatives promoting generics.
What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.
